Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Haller

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancerJ P Stevenson, M Redlinger, L A Kluijtmans, et al.
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
American Journal of Clinical Oncology|August 1, 1995
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group studyJ L Clark, O Küçük, D S Neuberg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology GroupT J Smith, L M Ryan, H O Douglass, et al.
The New England Journal of Medicine|August 25, 1994
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgeryM J O'Connell, J A Martenson, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283J E Harris, L Ryan, H C Hoover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trialsD G Haller, M J O'Connell, T H Cartwright, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year updateJ H Glick, B L Fowble, D G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process surveyB D Minsky, L Coia, D G Haller, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancerJ P Stevenson, M Redlinger, L A Kluijtmans, et al.
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
American Journal of Clinical Oncology|August 1, 1995
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group studyJ L Clark, O Küçük, D S Neuberg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology GroupT J Smith, L M Ryan, H O Douglass, et al.
The New England Journal of Medicine|August 25, 1994
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgeryM J O'Connell, J A Martenson, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283J E Harris, L Ryan, H C Hoover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trialsD G Haller, M J O'Connell, T H Cartwright, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year updateJ H Glick, B L Fowble, D G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process surveyB D Minsky, L Coia, D G Haller, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Pageof 9